Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Healthcare Global Enterprises Limited Strong Buy (bullish), based on 9 analysts. Average price target: ₹816.00.
Top signal score 31 of 100
Buys €19M€20M Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,286 of 26,280 companies
35.6
score / 100
Value
31
Quality
40
FCF yld0.7%
Earn yld0.2%
EV/EBITDA22.7x
ROE1.9%
Gross mgn50%
Net mgn0.5%
Debt/EBITDA4.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
4,699 shares@ ₹675.002.5% of flowEquity SharesSEBI:d2a07fc17bb2c037fe39f83d98abbabfb8ee1413
25 of 295 declarations
About Healthcare Global Enterprises Limited
The only two purchases in the Healthcare Global Enterprises Limited record come from one filer. Aceso Company Pte Ltd filed a purchase of EUR 12,910,039 on June 1, 2023 and another of EUR 6,038,366 on June 30, 2022, which are the 2 purchases in the record, EUR 18.9 million in all. Sales of identical amounts on the same dates are filed by Dr B S Ajaikumar. Purchases thus make up 5% of open-market trades, against 38 sales worth EUR 20.0 million, with a median of EUR 12,985.
Among the other sales, the largest is EUR 249,930, by Bharatsinh S Gadhavi (Employees/Designated Employees), on March 25, 2026. Ashutosh Kumar files 14, of which 7 sales, and Venkataramanan P 13, of which 6 sales.
Read moreShow less
The rest of the record is 202 grants and 53 filings of another kind, out of 295 filings and 79 filers between September 6, 2021 and September 29, 2026. Filings appear on the same day as the trade at the median. Annual volume rises to 101 in 2025. The last twelve months hold 30 filings, of which 9 sales and no purchases. This Indian healthcare and pharma company has a market capitalisation of INR 82.2 billion, with 70.6% of the shares held by insiders.